Please assess the completion status of the following clinical trial:

Trial Title: A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Any patient with a hematologic or oncologic diagnosis in which allogeneic HSCT is thought to be beneficial, and in whom front-line therapy has already been applied.~2. Patients must have a related donor who is either a one, two or three out of six antigen mismatch at the HLA-A;B;DR loci.~3. Patients without a well-matched unrelated donor or those who have a disease status that precludes a wait for an identified unrelated donor.~4. Patients must adequate organ function:~   * LVEF of \>45%~  * FVC or FEV1 \>45% of predicted~  * Adequate liver function as defined by a serum bilirubin \<1.8, AST or ALT \< 2.5X upper limit of normal~  * Serum creatinine \< 2.0 mg/dl or creatinine clearance of \> 40 ml/min~5. Performance status \> 60% (Karnofsky)~6. Patients must be willing to use contraception if they have childbearing potential~7. Able to give informed consent~Exclusion Criteria:~1. An eligible HLA-identical sibling donor.~2. Performance status \< 60% (Karnosfsky)~3. HIV positive~4. Active involvement of the central nervous system with malignancy~5. Psychiatric disorder that would preclude patients from signing an informed consent~6. Pregnancy~7. Patients with life expectancy of \< 6 months for reasons other than their underlying hematologic/oncologic disorder.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Haploidentical Allogeneic Transplantation (Type: EXPERIMENTAL): Patients undergoing hematopoietic stem cell transplant from a partially matched related donor

Based on this trial design, predict the completion outcome and termination type (if applicable).